These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38643185)

  • 1. Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis.
    Wei XY; Zhang J; Zhang Y; Fu WZ; Zhong LG; Pan YD; Sun J; Liao XP; Liu YH; Zhou YF
    BMC Vet Res; 2024 Apr; 20(1):147. PubMed ID: 38643185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease.
    Hamel D; Richard-Mazet A; Voisin F; Böhne I; Fraisse F; Rauh R; Huang R; Kellermann M; Letendre L; Dumont P; Rehbein S
    Vet Med Sci; 2021 Mar; 7(2):455-464. PubMed ID: 33058489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of gamithromycin in pulmonary epithelial lining fluid in naturally occurring bovine respiratory disease in multisource commingled feedlot cattle.
    DeDonder KD; Apley MD; Li M; Gehring R; Harhay DM; Lubbers BV; White BJ; Capik SF; KuKanich B; Riviere JE; Tessman RK
    J Vet Pharmacol Ther; 2016 Apr; 39(2):157-66. PubMed ID: 26441021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of
    Yang Q; Liu X; Zhang C; Yong K; Clifton AC; Ding H; Liu Y
    Front Pharmacol; 2019; 10():1090. PubMed ID: 31680940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
    Balaje RM; Sidhu PK; Kaur G; Rampal S
    Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo antibacterial activity of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits (Oryctolagus cuniculus) - A preliminary study.
    Sitovs A; Skadins I; Purvina S; Bandere D
    J Vet Pharmacol Ther; 2023 Sep; 46(5):332-343. PubMed ID: 37060264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
    Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
    J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.
    Lu TY; Sun Z; Liang LY; Zhang J; Guo WL; Wang ZY; Sun J; Liao XP; Zhou YF
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38925653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity.
    Huang RA; Letendre LT; Banav N; Fischer J; Somerville B
    J Vet Pharmacol Ther; 2010 Jun; 33(3):227-37. PubMed ID: 20557439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
    Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
    J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against
    Wang RL; Liu P; Chen XF; Yao X; Liao XP; Liu YH; Sun J; Zhou YF
    Front Vet Sci; 2022; 9():945632. PubMed ID: 35898553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and Validation of Dosage Regimen for Ceftiofur against
    Mi K; Pu S; Hou Y; Sun L; Zhou K; Ma W; Xu X; Huo M; Liu Z; Xie C; Qu W; Huang L
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.